Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care.

ABSTRACT:

Background

Previous studies have shown that reducing drug-related problems (DRPs) may improve therapeutic outcomes in patients with Parkinson's disease (PD).

Aim

To investigate the impact of pharmacist participation in Parkinson's disease clinic on the number of DRPs, clinical outcomes, and the quality of life of PD patients.

Method

This single-blinded randomised controlled trial was conducted at the Parkinson's Disease and Movement Disorders Clinic. Patients aged ≥ 18 years, diagnosed with idiopathic PD for at least 3 years, and receiving antiparkinsonian drugs were randomly assigned (1:1) to the pharmacist-physician (PP) or usual care (UC) groups. The primary outcome was changes in the number of DRPs from baseline to 24 weeks between groups. Secondary outcomes inclu

SUBMITTER: Techa-Angkoon P 

PROVIDER: S-EPMC12125048 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature